Myriad Genetics Stock Price - MYGN

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 30.57 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Myriad Genetics Inc MYGN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.15 0.49% 30.57 30.80 30.06 30.20 30.42 19:59:43
Bid Price Ask Price Spread Spread % News
16.10 38.00 21.90 57.63% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,715 363,389 $ 30.37 $ 11,037,829 1,003,570 21.00 - 48.40
Last Trade Time Type Quantity Stock Price Currency
16:42:14 91 $ 30.57 USD

Myriad Genetics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.26B 73.87M $ 131.10M 0.05 562.80 70.84M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 6.00 4.10%

more financials information »

Myriad Genetics News

Loading Messages....

Latest MYGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYGN Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week29.2330.9329.09529.9085485k1.344.58%
1 Month27.931.2226.6229.1699911k2.679.57%
3 Months28.1548.42131.82831M2.428.60%
6 Months32.0548.42129.57071M-1.48-4.62%
1 Year44.5648.42130.70191M-13.99-31.40%
3 Years19.4950.4415.1528.5306980k11.0856.85%
5 Years35.0150.4415.1530.0867947k-4.44-12.68%

Myriad Genetics Description

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.

Your Recent History
Myriad Gen..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.